XYWAV
XYWAV
Approved
DIN Number
02538237
Drug Class
Human
Market Date
Oct 4, 2023
Company
HC
JAZZ PHARMACEUTICALS IRELAND LIMITED
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02538237
AIG Number0464702001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule G (CDSA I)
A
ATC Code
N07XX04 HYDROXYBUTYRIC ACID
Product Specifications
Dosage FormSolution
Route of AdministrationOral
AHFS Classification28:92.00
Health Canada Classification
ACTIVE INGREDIENTS (4)
CALCIUM OXYBATEActive
Strength: 0.234 G / ML
Monograph: CALCIUM OXYBATE
MAGNESIUM OXYBATEActive
Strength: 0.096 G / ML
Monograph: MAGNESIUM OXYBATE
POTASSIUM OXYBATEActive
Strength: 0.13 G / ML
Monograph: POTASSIUM OXYBATE
SODIUM OXYBATEActive
Strength: 0.04 G / ML
Monograph: SODIUM OXYBATE